Agilent Technologiesvs.Illumina
A vs ILMN · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Agilent Technologies is about 1.4× larger than Illumina by market cap; Agilent Technologies trades at the lower P/E (29.4 vs 34.7); year to date, Illumina leads (+70.2% vs +12.8%).
Side by side
| A | ILMN | |
|---|---|---|
| Market cap | $41.5B | $28.7B |
| Price | $154.77 | $224.99 |
| Today | +0.9% | +0.8% |
| Return YTD | +12.8% | +70.2% |
| Return 1Y | +26.1% | +119.3% |
| P/E | 29.4 | 34.7 |
| P/S | 5.7 | 6.4 |
| P/B | 5.8 | 10.1 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Agilent TechnologiesA
Laboratory analysis is the business: LC/MS and other analytical instruments, sold with the consumables and diagnostic reagents that keep them running.
Full A profile →IlluminaILMN
DNA sequencing machines and the reagents they consume, for research and clinical genomics.
Full ILMN profile →More A & ILMN comparisons
Other head-to-heads in the Life science tools segment.
See where A and ILMN sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →